Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AUROBINDO PHARMA ABBOTT INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 50.0 23.0 217.5% View Chart
P/BV x 18.2 2.4 765.2% View Chart
Dividend Yield % 1.2 0.3 438.0%  

Financials

 ABBOTT INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
AUROBINDO PHARMA
Mar-23
ABBOTT INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs22,482715 3,146.1%   
Low Rs16,156397 4,066.4%   
Sales per share (Unadj.) Rs2,517.0424.2 593.4%  
Earnings per share (Unadj.) Rs446.832.9 1,358.1%  
Cash flow per share (Unadj.) Rs479.754.1 886.1%  
Dividends per share (Unadj.) Rs325.003.00 10,833.3%  
Avg Dividend yield %1.70.5 311.8%  
Book value per share (Unadj.) Rs1,480.5458.1 323.2%  
Shares outstanding (eoy) m21.25585.94 3.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.71.3 585.6%   
Avg P/E ratio x43.216.9 255.9%  
P/CF ratio (eoy) x40.310.3 392.2%  
Price / Book Value ratio x13.01.2 1,075.1%  
Dividend payout %72.79.1 797.7%   
Avg Mkt Cap Rs m410,513325,753 126.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,63635,223 16.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,487248,554 21.5%  
Other income Rs m1,5432,906 53.1%   
Total revenues Rs m55,030251,460 21.9%   
Gross profit Rs m12,05537,070 32.5%  
Depreciation Rs m70012,446 5.6%   
Interest Rs m1601,405 11.4%   
Profit before tax Rs m12,73826,125 48.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,2446,849 47.4%   
Profit after tax Rs m9,49419,277 49.3%  
Gross profit margin %22.514.9 151.1%  
Effective tax rate %25.526.2 97.2%   
Net profit margin %17.87.8 228.9%  
BALANCE SHEET DATA
Current assets Rs m30,251214,599 14.1%   
Current liabilities Rs m12,060114,938 10.5%   
Net working cap to sales %34.040.1 84.8%  
Current ratio x2.51.9 134.3%  
Inventory Days Days8721 421.3%  
Debtors Days Days266 3.3%  
Net fixed assets Rs m15,135176,668 8.6%   
Share capital Rs m213586 36.3%   
"Free" reserves Rs m31,248267,813 11.7%   
Net worth Rs m31,460268,399 11.7%   
Long term debt Rs m06,190 0.0%   
Total assets Rs m45,386392,125 11.6%  
Interest coverage x80.719.6 411.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.6 185.9%   
Return on assets %21.35.3 403.3%  
Return on equity %30.27.2 420.2%  
Return on capital %41.010.0 408.9%  
Exports to sales %0.433.7 1.2%   
Imports to sales %10.815.3 70.4%   
Exports (fob) Rs m22183,703 0.3%   
Imports (cif) Rs m5,76538,060 15.1%   
Fx inflow Rs m31085,483 0.4%   
Fx outflow Rs m5,81841,447 14.0%   
Net fx Rs m-5,50844,036 -12.5%   
CASH FLOW
From Operations Rs m8,93423,868 37.4%  
From Investments Rs m-1,477-39,778 3.7%  
From Financial Activity Rs m-6,38718,144 -35.2%  
Net Cashflow Rs m1,0702,298 46.6%  

Share Holding

Indian Promoters % 0.0 48.8 -  
Foreign collaborators % 75.0 3.1 2,442.7%  
Indian inst/Mut Fund % 8.9 41.3 21.6%  
FIIs % 0.2 20.7 0.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.2 51.9%  
Shareholders   72,252 241,944 29.9%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Aurobindo Pharma Share Price Performance

Period Abbott India Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 0.74% 1.82% 1.18%
1-Month -5.97% 5.96% -0.75%
1-Year 24.80% 113.07% 61.82%
3-Year CAGR 21.40% 7.78% 18.16%
5-Year CAGR 29.91% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.